Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 347 of 6351
-
Can plasma given right away save more burn victims?
Disease control Recruiting nowThe Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) trial will be a 5-year (3-year enrollment), open label, phase-3, multi-center, early in-hospital phase randomized trial utilizing burn centers from within the LITES network and w…
Phase 3 • Sponsor: Jason Sperry • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New combo therapy aims to fight aggressive brain tumors in kids
Disease control PausedThis is a multisite, phase I/II clinical trial in children and young adults with newly-diagnosed high-grade glioma (HGG), diffuse midline glioma (DMG) and recurrent HGG/DMG, Medulloblastoma (MB), or ependymoma (EPN) to determine the safety, immunogenicity, and efficacy of a CMV-d…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for cancer patients: experimental drug aims to stop dangerous blood clots
Disease control Recruiting nowThis study is researching an experimental drug called REGN7508 (called "study drug") and will consist of 2 parts: Part 1 and Part 2. The study is focused on participants with or without cancer who develop blood clots in certain veins (called Deep Vein Thrombosis \[DVT\]) that blo…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Womb surgery for rare birth defect: will it save more babies?
Disease control By invitation onlyThe purpose of this research is to determine if babies who undergo a Fetoscopic Endoluminal Tracheal Occlusion (FETO) procedure survive more often and have less long-term complications than babies who have similarly severe Congenital Diaphragmatic Hernia (CDH) that have not had t…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Experimental drug cocktail takes on childhood brain cancers
Disease control Not yet recruitingThis study is researching an experimental drug called cemiplimab (called "study drug") and the combination of experimental drugs of fianlimab and cemiplimab (called "study drugs"). The study is focused on children and young adults with recurrent or progressive High-Grade Glioma (…
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo aims to tame HPV throat cancer with fewer side effects
Disease control Not yet recruitingThis research study is testing whether a new study drug (called ATRN-119) is safe and effective when combined with a single, highly targeted dose of radiation therapy (called stereotactic body radiation therapy or SBRT) to treat early-stage throat cancer that is caused by HPV. T…
Phase 1/2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a statin make breast cancer therapy more effective?
Disease control Not yet recruitingThe purpose of this study is to evaluate use of lovastatin, a drug that may lower CAV-1 levels, in order to increase HER2 expression on cells and enhance the uptake and efficacy of trastuzumab deruxtecan (T-DXd) in HER2-low and ultralow advanced metastatic breast cancer. Trastuzu…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug aims to cut heart risk for patients with high lp(a) after heart attack
Disease control Not yet recruitingCTQJ230A1US13 is a randomized, double-blind, placebo-controlled, multicenter phase IIIb study designed to evaluate the efficacy, safety, tolerability, and coronary plaque effects of early pelacarsen (TQJ230) initiation in participants with elevated Lp(a) and recent acute coronary…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Laser zaps brain tumor, then immunotherapy fights back: new hope for glioblastoma?
Disease control Not yet recruitingThis study will assess the therapeutic efficacy of the combination of Laser Interstitial Thermal Therapy (LiTT) with adjuvant cemiplimab compared to the therapeutic efficacy of the combination of LiTT with physician's choice of adjuvant chemotherapy in patients with recurrent gli…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Heart-Safe chemo? trial aims to shield patients from lifelong damage
Disease control Recruiting nowThis trial is to evaluate if dexrazoxane is safer and more effective than liposomal doxorubicin in preventing heart failure events in participants with diffuse large B-cell lymphoma (DLBCL) undergoing either standard of care R-CHOP or pola-R-CHP treatment regiments. The names of…
Phase 2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug takes aim at hard-to-treat neuroendocrine prostate cancer
Disease control Not yet recruitingThis is a phase 2, open-label, single-arm study of sacituzumab tirumotecan in neuroendocrine prostate cancer (NEPC) with progression after platinum-based chemotherapy.
Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Two-Drug cocktail aims to shrink Hard-to-Treat esophageal and stomach tumors
Disease control Not yet recruitingThis is a single-arm, multi-center phase II study to evaluate the efficacy and safety of sacituzumab tirumotecan (Sac-TMT/SKB264) combined with tagitanlimab (KL-A167) as 2nd line therapy for recurrent or metastatic esophageal squamous cell carcinoma (ESCC) or gastric/gastroesopha…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a smartphone program supervised by AI boost recovery after stomach cancer surgery?
Symptom relief Not yet recruitingThe goal of this prospective, multicenter, open-label randomized controlled clinical trial is to evaluate whether a home-based, digitally supervised multi-modal prehabilitation intervention can improve functional capacity, treatment tolerance, and short- and long-term clinical ou…
Sponsor: The Affiliated Hospital of Qingdao University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can lower pressure make complex surgery safer and speed recovery?
Disease control Not yet recruitingWhen performing minimally invasive (MIS) hepato-pancreato-biliary (HPB) surgery, an air seal is used for optimal space and visibility of the surgical field. This is typically done at a pressure of 10-15 mmHg, but can also come with risks of serious complications. HBP surgeries ar…
Sponsor: Juan Glinka • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a 100,000-Patient global audit reveal how to make surgery safer?
Knowledge-focused Not yet recruitingThis study aims to assess and improve the global outcomes following surgery. Every year approximately 313 million operations are performed, with 50 million people experiencing a complication and unfortunately 3.5 million people will die following these operations. This study will…
Sponsor: University of Birmingham • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Can a needle in the face tame allergy symptoms?
Symptom relief Not yet recruitingAllergic rhinitis can cause sneezing, a runny or blocked nose, and nasal itching, which may affect daily activities and quality of life. Nasal corticosteroid sprays are commonly used to control these symptoms, but some people may still have bothersome symptoms. The purpose of th…
Sponsor: Zhongshan Torch Development Zone People's Hospital • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Olive oil and fish: a recipe for a healthier liver?
Prevention Recruiting nowThis prospective randomized dietary intervention study investigates the effects of two dietary approaches on liver health in young adults over a 12-week period. Participants will be randomly assigned to either a Mediterranean diet intervention or a healthy diet based on general d…
Sponsor: Hochschule Campus Wien (University of Applied Sciences Campus Vienna) • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Magnetic pulses to the brain may help cancer patients sleep better
Symptom relief Not yet recruitingThis randomized, double-blind, sham-controlled trial will evaluate whether low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve in-hospital sleep quality in adults with advanced non-small cell lung cancer (NSCLC) and clinically significant in-hospital sle…
Phase 2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Magnetic pulses to the brain may help lung cancer patients sleep after surgery
Symptom relief Not yet recruitingThis randomized, double-blind, sham-controlled trial will evaluate whether perioperative low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve early postoperative in-hospital sleep quality in adults undergoing elective thoracoscopic lung resection for prim…
Phase 2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Digital twin of the human body may forecast health decline before it happens
Knowledge-focused By invitation onlyTRU-OMNIBODY is a prospective observational study designed to develop and independently validate a research-only whole-body digital twin. The digital twin will combine measurements from multiple body systems to create a participant-specific representation of physiologic state, re…
Sponsor: Truway Health, Inc. • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC